Singular Genomics Systems Inc (OMIC)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
CEO:
Andrew Spaventa
Employees:
230
10931 N. TORREY PINES ROAD, SUITE #100, LA JOLLA, CA 92037
(858) 333-7830

Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology. The company manufactures G4 Instrument, a benchtop next generation sequencer, as well as associated menu of consumable kits. It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument.

Data derived from most recent annual or quarterly report
Market Cap 0 Shares Outstanding0 Avg 30-day Volume 107.71 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-1.18
Price to Revenue0.0 Debt to Equity0.0313 EBITDA-93.789 Million
Price to Book Value1.4029 Operating Margin0.0 Enterprise Value139.36 Million
Current Ratio35.872 EPS Growth0 Quick Ratio34.791
1 Yr BETA 1.8667 52-week High/Low 10.29 / 1.8 Profit Margin0.0
Operating Cash Flow Growth0.0 Altman Z-Score10.3158 Free Cash Flow to Firm 0
Earnings Report2023-03-01
View SEC Filings from OMIC instead.

View recent insider trading info

Funds Holding OMIC (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding OMIC

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

50 Thousand total shares from 1 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GLEZER ELI N. CHIEF SCIENTIFIC OFFICER

  • Officer
4,185,000 2022-12-12 2

BARKER DAVID L

  • Director
1,060,000 2022-07-07 2

PELLINI MICHAEL J

  • Director
351,222 2022-05-31 3

MARDIS ELAINE R

  • Director
19,271 2022-05-26 1

KAMDAR KIM P.

  • Director
46,250 2022-05-26 1

RYAN JASON

  • Director
46,250 2022-05-26 1

SPAVENTA ANDREW CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
4,423,337 2022-03-24 2

DALY DAVID PRESIDENT AND CHIEF OPERATING

  • Officer
0 2022-03-04 1

MEETER DALEN SENIOR VICE PRESIDENT, FINANCE

  • Officer
187,500 2022-03-04 1

FLYNN JAMES E

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

DEERFIELD PARTNERS, L.P.

DEERFIELD MGMT L.P.

DEERFIELD MGMT IV, L.P.

DEERFIELD PRIVATE DESIGN FUND IV, L.P.

  • 10% Owner
  • *POSSIBLE MEMBER OF 10% GROUP*POSSIBLE MEMBER OF 10% GROUP*POSSIBLE MEMBER OF 10% GROUP*POSSIBLE MEMBER OF 10% GROUP*POSSIBLE MEMBER OF 10% GROUP*POSSIBLE MEMBER OF 10% GROUP
9,142,019 2021-06-01 0

ALEXANDRIA VENTURE INVESTMENTS, LLC

  • 10% Owner
No longer subject to file 2021-06-01 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

GLEZER ELI N. - Officer CHIEF SCIENTIFIC OFFICER

2022-12-13 18:14:54 -0500 2022-12-12 P 50,000 $2.00 a 4,185,000 direct -5.0633 -8.0169 0.0 1 -18.1435 4

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
SINGULAR GENOMICS SYSTEMS IN OMIC 2023-01-30 22:15:03 UTC 1.4199 2.9001 150000
SINGULAR GENOMICS SYSTEMS IN OMIC 2023-01-30 21:45:04 UTC 1.4199 2.9001 150000
SINGULAR GENOMICS SYSTEMS IN OMIC 2023-01-30 21:15:03 UTC 1.4199 2.9001 150000
SINGULAR GENOMICS SYSTEMS IN OMIC 2023-01-30 20:45:03 UTC 1.4199 2.9001 150000
SINGULAR GENOMICS SYSTEMS IN OMIC 2023-01-30 20:15:03 UTC 1.4199 2.9001 150000
SINGULAR GENOMICS SYSTEMS IN OMIC 2023-01-30 19:45:03 UTC 1.4199 2.9001 150000
SINGULAR GENOMICS SYSTEMS IN OMIC 2023-01-30 19:15:04 UTC 1.4199 2.9001 150000
SINGULAR GENOMICS SYSTEMS IN OMIC 2023-01-30 18:45:04 UTC 1.4199 2.9001 150000
SINGULAR GENOMICS SYSTEMS IN OMIC 2023-01-30 18:15:03 UTC 1.4199 2.9001 150000
SINGULAR GENOMICS SYSTEMS IN OMIC 2023-01-30 17:45:03 UTC 1.4199 2.9001 150000
SINGULAR GENOMICS SYSTEMS IN OMIC 2023-01-30 17:15:03 UTC 1.4199 2.9001 150000
SINGULAR GENOMICS SYSTEMS IN OMIC 2023-01-30 16:45:04 UTC 1.4199 2.9001 150000
SINGULAR GENOMICS SYSTEMS IN OMIC 2023-01-30 16:15:03 UTC 1.4199 2.9001 150000
SINGULAR GENOMICS SYSTEMS IN OMIC 2023-01-30 15:45:03 UTC 1.4199 2.9001 150000
SINGULAR GENOMICS SYSTEMS IN OMIC 2023-01-30 15:15:03 UTC 1.4199 2.9001 150000
SINGULAR GENOMICS SYSTEMS IN OMIC 2023-01-30 14:45:04 UTC 1.4199 2.9001 150000
SINGULAR GENOMICS SYSTEMS IN OMIC 2023-01-30 14:15:03 UTC 1.4199 2.9001 150000
SINGULAR GENOMICS SYSTEMS IN OMIC 2023-01-30 13:45:04 UTC 1.4439 2.8761 150000
SINGULAR GENOMICS SYSTEMS IN OMIC 2023-01-30 13:15:04 UTC 1.4439 2.8761 150000
SINGULAR GENOMICS SYSTEMS IN OMIC 2023-01-30 12:45:04 UTC 1.4439 2.8761 150000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments